Form 4: Rocket Pharmaceuticals CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Aaron Ondrey, CFO of Rocket Pharmaceuticals, sold 7,489 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
Summary
- On April 4, 2025, Aaron Ondrey, the Chief Financial Officer of Rocket Pharmaceuticals, sold 7,489 shares of common stock.
- The sale was executed at a price of $5.294 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Ondrey directly owns 129,650 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports a stock sale by the CFO to cover tax obligations, which is a routine transaction.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 04/04/2025 | Date of stock sale transaction |
| 04/08/2025 | Date of Form 4 filing |
Keywords
Rocket Pharmaceuticals, Aaron Ondrey, CFO, stock sale, Form 4, RSU, tax obligations, RCKT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.